Wednesday, January 31, 2018

January 2018 Results

January was yet another good month for our US portfolio. It ended with +4.31%, making it the 15th month in a row with a positive result. At a time the portfolio was almost up even more than the 4.31%. However, looking at how things have developed over the last few years it’s clear that this is not sustainable. Eventually the real economy has to catch up to what the markets do. And if that doesn’t happen or does not happen to the degree required, then the markets will have to adjust. A first taste were the two days with triple digit losses of the Dow Jones on 29 January and 30 January.

We believe that there are three main reasons the US markets made so much progress in January. Firstly, the tax reform helped a number of businesses to take a windfall. They opted for either buying back more shares, increasing the dividend or to pay a one-off bonus to their employees. Or a combination of these. Another factor was that some companies reported results that were better even if you exclude the change in the US tax rules. AbbVie (ABBV) is one such example. Finally, because the US dollar weakened compared to some currencies, US shares looked more attractive. For example the EUR was USD 1.2457 on 31 January 2018 compared to USD 1.0755 on 31 January 2018, a change of 15.8%. Taking this into account the increase of the S&P 500 over the same period (+23.91%) is still a very good value but doesn’t really look as impressive anymore.

As always let’s look at how our US portfolio performed compared to its benchmarks. The portfolio is up 27.87% year-to-year. In the same timeframe the S&P 500 is up 23.91%, so our portfolio is ahead by 3.96%. This figure is down from 4.31% last month, mainly because of how Procter & Gamble (PG), Johnson & Johnson (JNJ) and Atlassian (TEAM) performed. For all three we continue to be optimistic long-term.

Let’s look at another two benchmarks. One is the S&P 500 Dividend Aristocrats (SPDAUD) and the other ProShares S&P 500 Dividend Aristocrats ETF (NOBL). Using 31 December 2016 as 100%, our portfolio is 5.83% ahead of SPDAUD (+4.91% in December) and 6.25% ahead of NOBL (+5.18% in December) as of 31 January 2018.

Note that the S&P 500 had an annualized return over the last 10 years of about 6.93%, SPDAUD of 8.89% and NOBL of 13.89% (NOBL since inception 09 Oct 2013). Over the 12 months ending 31 January 2018 our US portfolio beat all three of these by at least 3.96%.

Please be aware that past results do not guarantee future results. Also, keep in mind that perhaps we were just lucky picking the rights stocks when we started this portfolio in January 2017. The early indicators suggest that choosing a good balance between about 70% to 90% of dividend aristocrats and 10% to 30% of hand-picked other stock might yield good results for the increased risk.

Happy investing!

Disclosure: We own shares of ABBV, TEAM, JNJ and PG. We have no plans to change our position in the next 48 hours after publication for any of the financial instruments mentioned in this post. S&P 500, ProShares, etc. are trademarks of their respective owners.

No comments:

Post a Comment

Please note comments are moderated to ensure high-quality content. Opposing views are welcome!